David A. Siegel Bridge Bio Pharma, Inc. Transaction History

Two Sigma Advisers, LP

$47 Billion
Q3 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,662,755 shares of BBIO stock, worth $110 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,662,755

Previous 1,684,055 1.26%

Holding current value

$110 Million

Previous $72.7 Million 18.77%

% of portfolio

0.18%

Previous 0.16%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$42.78 - $54.29 $911,214 - $1.16 Million	-21,300 Reduced 1.26%	1,662,755 $86.4 Million
Q2 2025 Aug 14, 2025	BUY	$30.14 - $45.12 $42.5 Million - $63.7 Million	1,410,900 Added 516.52%	1,684,055 $72.7 Million
Q1 2025 May 15, 2025	BUY	$28.12 - $37.59 $7.68 Million - $10.3 Million	273,155 New	273,155 $9.44 Million
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $5.07 Million - $6.63 Million	-211,965 Reduced 83.84%	40,855 $1.04 Million
Q2 2024 Aug 14, 2024	SELL	$23.0 - $31.04 $1.13 Million - $1.52 Million	-49,035 Reduced 16.24%	252,820 $6.4 Million

Q1 2024 May 15, 2024	SELL	$27.35 - $40.45 $1.64 Million - $2.42 Million	-59,900 Reduced 16.56%	301,855 $9.33 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $391,526 - $715,407	-16,300 Reduced 4.31%	361,755 $14.6 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $290,339 - $601,821	-17,190 Reduced 4.35%	378,055 $9.97 Million
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $1.01 Million - $1.37 Million	76,110 Added 23.85%	395,245 $6.8 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $557,109 - $1.44 Million	77,700 Added 32.18%	319,135 $5.29 Million
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $35,486 - $60,652	-5,265 Reduced 2.13%	241,435 $1.84 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $1.63 Million - $2.54 Million	205,420 Added 497.63%	246,700 $2.45 Million
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $71,898 - $167,532	13,800 Added 50.22%	41,280 $375,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $194,179 - $453,967	-26,455 Reduced 49.05%	27,480 $279,000
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $1.08 Million - $5.09 Million	-95,315 Reduced 63.86%	53,935 $900,000
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $5.06 Million - $6.94 Million	-108,000 Reduced 41.98%	149,250 $7 Million
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $8.79 Million - $12.1 Million	-189,200 Reduced 42.38%	257,250 $15.7 Million
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $17.8 Million - $23.2 Million	320,550 Added 254.61%	446,450 $27.5 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $4.83 Million - $8.95 Million	125,900 New	125,900 $8.95 Million

Others Institutions Holding BBIO

# of Institutions

446

Shares Held

184M

Call Options Held

11.3M

Put Options Held

1.84M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $9.84B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account